Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Over the last 12 months, insiders at Forte Biosciences, Inc. have bought $150,162 and sold $0 worth of Forte Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Forte Biosciences, Inc. have bought $226,228 and sold $4.45M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Riley Antony A (CHIEF FINANCIAL OFFICER) — $249,995. Wagner Paul A. (See Remarks) — $25,165.
The last purchase of 22,514 shares for transaction amount of $124,998 was made by Riley Antony A (CHIEF FINANCIAL OFFICER) on 2024‑11‑21.
2024-11-21 | CHIEF FINANCIAL OFFICER | 22,514 0.5477% | $5.55 | $124,998 | +50.00% | |||
2023-12-18 | See Remarks | 10,000 0.0286% | $0.75 | $7,525 | -15.53% | |||
2023-12-14 | See Remarks | 10,000 0.0287% | $0.72 | $7,200 | -11.90% | |||
2023-12-13 | See Remarks | 10,520 0.0284% | $0.70 | $7,351 | -12.86% | |||
2023-12-12 | See Remarks | 4,776 0.013% | $0.65 | $3,088 | -6.84% | |||
2023-12-11 | See Remarks | 25,000 0.0719% | $0.65 | $16,188 | 0.00% | |||
2023-12-08 | See Remarks | 15,000 0.0406% | $0.62 | $9,300 | 0.00% | |||
2023-12-07 | See Remarks | 36,203 0.0971% | $0.58 | $21,168 | +5.17% | |||
2023-11-22 | See Remarks | 400 0.0011% | $0.43 | $172 | +37.86% | |||
2023-11-20 | See Remarks | 6,966 0.0175% | $0.44 | $3,048 | +21.00% | |||
2022-12-16 | See Remarks | 44,024 0.2759% | $1.07 | $47,000 | +2.04% | |||
2022-12-15 | See Remarks | 55,976 0.3253% | $1.03 | $57,672 | -1.96% | |||
2021-09-07 | Sale | See Remarks | 1M 7.2851% | $4.35 | $4.35M | -65.57% | ||
2021-09-07 | Sale | Chief Financial Officer | 25,000 0.1778% | $4.24 | $106,105 | -65.57% | ||
2020-06-29 | Chief Financial Officer | 2,000 0.0544% | $14.11 | $28,220 | +145.46% | |||
2020-06-26 | Chief Financial Officer | 4,700 0.1262% | $14.52 | $68,225 | +135.52% | |||
2020-06-25 | See Remarks | 7,000 0.1998% | $14.48 | $101,356 | +150.76% | |||
2020-04-14 | 10 percent owner | 74,301 0.1242% | $1.19 | $88,418 | +54.56% | |||
2020-03-02 | 10 percent owner | 65,149 0.0283% | $1.35 | $87,756 | -0.52% | |||
2019-05-30 | director | 43,000 0.0242% | $4.66 | $200,315 | -77.34% |
Wagner Paul A. | See Remarks | 1823236 124.7143% | $23.45 | 12 | 1 | +50.28% |
Riley Antony A | CHIEF FINANCIAL OFFICER | 30776 2.1052% | $23.45 | 3 | 1 | +140.49% |
Oliveira Steven Michael | 10 percent owner | 2873450 196.5518% | $23.45 | 2 | 0 | +27.02% |
Hasnain Faheem | director | 245857 16.8173% | $23.45 | 2 | 0 | |
FOLETTA MARK G | EVP & Chief Financial Officer | 15042 1.0289% | $23.45 | 2 | 0 | |
SCHIMMEL PAUL | director | 13623 0.9319% | $23.45 | 1 | 0 | |
Duvall Martin J | Chief Executive Officer | 13605 0.9306% | $23.45 | 1 | 0 | |
GRUBER HARRY E | President, Science&Innovation | 9744 0.6665% | $23.45 | 2 | 0 | |
Das Asha | SVP & Chief Medical Officer | 2500 0.171% | $23.45 | 1 | 0 |
Tybourne Capital Management HK Ltd | $2.52M | 9.95 | 3.62M | 0% | +$0 | 0.43 | |
Perceptive Advisors | $2.27M | 8.96 | 3.27M | 0% | +$0 | <0.01 | |
Bvf Inc Il | $2.09M | 8.18 | 2.98M | 0% | +$0 | 0.02 | |
Alger | $1.28M | 5.05 | 1.84M | 0% | +$0 | 0.01 | |
Farallon Capital | $1.27M | 4.97 | 1.81M | 0% | +$0 | 0.01 | |
Bml Capital Management Llc | $1.23M | 4.83 | 1.76M | 0% | +$0 | 0.94 | |
The Vanguard Group | $463,133.00 | 1.83 | 665,230 | 0% | +$0 | <0.0001 | |
Geode Capital Management | $240,705.00 | 0.94 | 343,432 | +2.03% | +$4,784.91 | <0.0001 | |
BlackRock | $121,736.00 | 0.48 | 174,858 | -4.09% | -$5,197.82 | <0.0001 | |
Renaissance Technologies | $92,000.00 | 0.36 | 132,100 | +1.77% | +$1,601.82 | <0.0001 | |
State Street | $29,194.00 | 0.11 | 41,664 | 0% | +$0 | <0.0001 | |
Two Sigma | $28,450.00 | 0.11 | 40,864 | -0.24% | -$69.62 | <0.0001 | |
Citadel Advisors LLC | $19,774.00 | 0.08 | 28,220 | +227.49% | +$13,735.99 | <0.0001 | |
Northern Trust | $18,735.00 | 0.07 | 26,911 | 0% | +$0 | <0.0001 | |
Two Sigma Advisers LP | $17,259.00 | 0.07 | 24,791 | 0% | +$0 | <0.0001 | |
Goldman Sachs | $14,463.00 | 0.06 | 20,774 | +0.16% | +$23.67 | <0.0001 | |
Group One Trading | $10,179.00 | 0.04 | 14,527 | -8.21% | -$910.90 | <0.0001 | |
Aries Wealth Management | $9,051.00 | 0.04 | 13,000 | 0% | +$0 | <0.01 | |
Tower Research Capital | $8,103.00 | 0.03 | 11,642 | +101.38% | +$4,079.34 | <0.0001 | |
TWO SIGMA SECURITIES LLC | $7,743.00 | 0.03 | 11,122 | -27.93% | -$3,000.57 | <0.0001 | |
HSBC | $7,529.00 | 0.03 | 10,745 | 0% | +$0 | <0.0001 | |
Advisor Group Holdings Inc | $754.00 | <0.01 | 1,080 | 0% | +$0 | <0.0001 | |
Morgan Stanley | $692.00 | <0.01 | 994 | 0% | +$0 | <0.0001 | |
Russell Investments Group Ltd | $317.00 | <0.01 | 453 | 0% | +$0 | <0.0001 | |
Loring Wolcott Coolidge Fiduciary Advisors Llp Ma | $139.00 | <0.01 | 193 | 0% | +$0 | <0.0001 | |
Wells Fargo | $176.00 | <0.01 | 253 | +2.02% | +$3.48 | <0.0001 | |
UBS | $23.00 | <0.01 | 33 | -77.4% | -$78.76 | <0.0001 | |
Royal Bank of Canada | $0 | <0.01 | 137 | New | +$0 | <0.0001 | |
Qube Research & Technologies | $2.00 | <0.01 | 3 | 0% | +$0 | <0.0001 | |
JPMorgan Chase | $12.00 | <0.01 | 17 | 0% | +$0 | <0.0001 |